FIGS Is Up 12% in a Week. Is Its Raised Outlook Really That Good?

FIGS stock rose 12% after Q3 revenue grew 25.7% and the company raised its full-year outlook. Analysts increased price targets, with Barclays at $28 and KeyBanc at $27. FIGS expects 24% growth for 2026, up from 20%, and adjusted EBITDA margin of 15.8%. Analysts now expect 2027 EPS of $0.42, up from $0.38.

Original reporting
Published Nov 13, 2026, 1:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 14, 2026, 1:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FIGS Is Up 12% in a Week. Is Its Raised Outlook Really That Good? — source image
Decision brief

The 30-second read

$FIGSNeutralLow
01

Why it matters

Recap provides no new data; traders gain no actionable insight beyond what was already known.

02

Market read

Low relevance; repeats prior earnings release without new information.

03

What to watch

Potential supply risk from Jordanian supplier blockage could affect Q2 2027 performance.

Relevance 4/10Novelty 2/10Timing: none

Background

The article summarizes FIGS' Q3 earnings, revenue growth, margin improvement, and raised full‑year outlook, all disclosed on Nov 5.

Company-level read

Ticker impact

$FIGSNeutralHigh confidence
Context

Article recaps Q3 results and raised outlook that were released 8 days earlier; no new corporate action.

Expected impact

limited upside pressure as investors digest guidance; no immediate directional move expected

Evidence & confidence

The piece only repeats already‑public earnings numbers and guidance, offering no new information to drive price.

Market effects

None; article focuses on a single company.

None

None

Counterpoint

Without a new catalyst, the stock may face profit‑taking after the 12% rally.

Key entities

  • FIGS

    Medical apparel maker (NASDAQ: FIGS).

Related articles

$FIGSHighAI 8/10

Cantor Fitzgerald initiates Figs stock with overweight rating

Cantor Fitzgerald initiated coverage on Figs Inc. (NYSE:FIGS) with an overweight rating and a $25.00 price target. The stock trades at $21.58 with a $3.58B market cap. Figs reported Q3 2026 core scrubs sales of $191M, up 26%, and raised fiscal 2026 sales guidance to 23.5%. The company's gross profit margin is 67.73%, and adjusted EBITDA margin is projected to rise to 18.4% by fiscal 2028. FIGS shares declined in after-hours trading despite beating earnings expectations.

$FIGSHighAI 8/10

Why Figs Stock Popped Today

Figs (FIGS) stock rose 7.8% after Q3 earnings beat estimates, with revenue up 26% YoY to $190.7M and EPS at $0.10. Core scrubs sales grew 24%, while non-scrubwear and international sales saw faster growth. Profit margins expanded to 10.1%. CEO Trina Spear expects momentum into 2027, but Q4 growth forecast is slower at 15%.

$FIGSMed

What FIGS (FIGS) Said on Its Q3 Earnings Call

FIGS reported Q3 revenue of $190.7M, up 21% in the U.S. and 51% internationally. Gross margin was 69.3%, down 60 bps but above expectations. Adjusted EBITDA margin rose to 16.5%. The company raised its full-year 2026 revenue growth forecast to 23.5% and adjusted its margin outlooks. FIGS faces supply chain challenges but expects to expand production capacity in Indonesia by 2027. Inventory fell 20% YoY to $121.3M.

$FIGSHighAI 8/10

FIGS Inc (FIGS) (Q3 2026) Earnings Call Highlights: Revenue Surges 26% as International

FIGS Inc reported Q3 2026 revenue of $190M, up 26% YoY, beating guidance despite supply constraints. CEO Trina Spear highlighted strong US growth, driven by e-commerce and hubs/Teams. CFO Sarah Altred cited revenue leverage, marketing efficiencies, and improved product mix for margin expansion. The company expects continued growth in 2027, with international markets and new categories like 'the Charmacy' as key drivers.